Literature DB >> 10721161

[Diagnostic spectrum and treatment requirements of general practice clients. Results of the ADT Panel of the Central Institute of National Health Insurance Management].

H Kerek-Bodden1, H Koch, G Brenner, G Flatten.   

Abstract

Results of the ADT-Panel of the Central Research Institute of ambulatory health care in Germany. The ADT-Panel of the Central Research Institute contains the remuneration data that are quarterly collected by office-based physicians and transmitted in anonymous form. These data can be classified according to the status of the insured patient, the diagnoses made or the treatment provided. The Patient Panel does therefore represent an important instrument which allows a rapid scientific analysis (3 to 4 weeks after the end of a quarter) about how patients are treated by different specialists. It might also be used to forecast trends. The Patient Panel does as well allow the demonstration of specialty-related statistics on diagnoses and disease-related treatment provision. The complete publication and some exemplary tables can be found in the DGN Internet (www.dgn.de; Deutsches Gesundheitsnetz). A short summary is available on the home page of the Central Research Institute (www/zi-koeln.de).

Entities:  

Mesh:

Year:  2000        PMID: 10721161

Source DB:  PubMed          Journal:  Z Arztl Fortbild Qualitatssich        ISSN: 1431-7621


  8 in total

1.  Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular diseases from Germany.

Authors:  Sebastian Harder; Philipp Fischer; Markus Krause-Schäfer; Klaus Ostermann; Gottfried Helms; Helge Prinz; Mike Hahmann; Horst Baas
Journal:  Eur J Clin Pharmacol       Date:  2004-12-01       Impact factor: 2.953

2.  Activating GENeral practitioners dialogue with patients on their Agenda (MultiCare AGENDA) study protocol for a cluster randomized controlled trial.

Authors:  Attila Altiner; Ingmar Schäfer; Christine Mellert; Christin Löffler; Achim Mortsiefer; Annette Ernst; Carl-Otto Stolzenbach; Birgitt Wiese; Martin Scherer; Hendrik van den Bussche; Hanna Kaduszkiewicz
Journal:  BMC Fam Pract       Date:  2012-12-12       Impact factor: 2.497

3.  Pharmacotherapy of elderly patients in everyday anthroposophic medical practice: a prospective, multicenter observational study.

Authors:  Elke Jeschke; Thomas Ostermann; Manuela Tabali; Horst C Vollmar; Matthias Kröz; Angelina Bockelbrink; Claudia M Witt; Stefan N Willich; Harald Matthes
Journal:  BMC Geriatr       Date:  2010-07-21       Impact factor: 3.921

4.  Benchmarking the burden of 100 diseases: results of a nationwide representative survey within general practices.

Authors:  Lamiae Grimaldi-Bensouda; Bernard Begaud; France Lert; Frederic Rouillon; Jacques Massol; Didier Guillemot; Bernard Avouac; Gerard Duru; Anne-Marie Magnier; Michel Rossignol; Lucien Abenhaim
Journal:  BMJ Open       Date:  2011-11-14       Impact factor: 2.692

5.  Health costs in anthroposophic therapy users: a two-year prospective cohort study.

Authors:  Harald J Hamre; Claudia M Witt; Anja Glockmann; Renatus Ziegler; Stefan N Willich; Helmut Kiene
Journal:  BMC Health Serv Res       Date:  2006-06-02       Impact factor: 2.655

6.  Insufficient depression treatment in outpatient settings.

Authors:  Frank Schneider; Sandra Kratz; Isaac Bermejo; Ralph Menke; Christoph Mulert; Ulrich Hegerl; Mathias Berger; Wolfgang Gaebel; Martin Härter
Journal:  Ger Med Sci       Date:  2004-02-26

7.  Eurythmy therapy in chronic disease: a four-year prospective cohort study.

Authors:  Harald J Hamre; Claudia M Witt; Anja Glockmann; Renatus Ziegler; Stefan N Willich; Helmut Kiene
Journal:  BMC Public Health       Date:  2007-04-23       Impact factor: 3.295

8.  Anthroposophic medical therapy in chronic disease: a four-year prospective cohort study.

Authors:  Harald J Hamre; Claudia M Witt; Anja Glockmann; Renatus Ziegler; Stefan N Willich; Helmut Kiene
Journal:  BMC Complement Altern Med       Date:  2007-04-23       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.